Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.6900 (-7.79%) ($7.4500 - $8.3900) on Wed. Apr. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.39% (three month average) | RSI | 51 | Latest Price | $7.6900(-7.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(4%) VXX(3%) BLOK(2%) IBB(2%) TBT(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.695% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.695% (StdDev 3.39%) | Hourly BBV | 0 () | Intraday Trend | -7.9% | | | |
|
Resistance Level | $8.28 | 5 Day Moving Average | $8.35(-7.9%) | 10 Day Moving Average | $8.5(-9.53%) | 20 Day Moving Average | $8.28(-7.13%) | To recent high | -20.9% | To recent low | 4.2% | Market Cap | $1.357b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |